The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

Currently, the only FDA-approved OTC weight loss drug is Alli, which uses a 60-milligram dose of orlistat versus 120 ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

New Yorkers are brazenly reselling prescription diabetic and weight ... “In addition, injectable weight loss drugs are often not covered by insurance, making some patients more likely to pay ...

A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.

The sudden surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record ...